Who
Yat Sun Or
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Enanta Pharmaceuticals.
In numbers
- Trades disclosed
- 132
- Buys
- 0
- Sells
- 20
- Bought
- $0
- Sold
- $8.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Dec 2013
- Last trade
- 12 Feb 2026
- Last filed
- 13 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Feb 2026filed 13 Feb 2026 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,650 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —5,225 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $49K3,413 at $14.25 | filing |
| 12 Feb 2026filed 13 Feb 2026 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,650 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —5,225 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $49K3,413 at $14.25 | filing |
| 5 Dec 2025filed 5 Dec 2025 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $34K2,390 at $14.23 | filing |
| 1 Dec 2025filed 3 Dec 2025 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $11K753 at $14.12 | filing |
| 25 Nov 2025filed 26 Nov 2025 | ENTA Enanta Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 12 Feb 2025filed 14 Feb 2025 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —9,750 at $0.00 | filing |
| 12 Feb 2025filed 14 Feb 2025 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $24K4,324 at $5.59 | filing |
| 6 Dec 2024filed 10 Dec 2024 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $21K2,591 at $8.06 | filing |
| 1 Dec 2024filed 3 Dec 2024 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $14K1,595 at $8.60 | filing |
| 27 Nov 2024filed 27 Nov 2024 | ENTA Enanta Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —87,000 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —3,680 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $13K1,080 at $12.41 | filing |
| 5 Dec 2023filed 6 Dec 2023 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $23K2,412 at $9.63 | filing |
| 1 Dec 2023filed 5 Dec 2023 | ENTA Enanta PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $15K1,595 at $9.49 | filing |
| 22 Nov 2023filed 22 Nov 2023 | ENTA Enanta Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —86,000 at $0.00 | filing |
| 15 Mar 2023filed 17 Mar 2023 | ENTA Enanta Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,925 at $0.00 | filing |
News
Comparing Amphastar Pharmaceuticals (NASDAQ:AMPH) & Enanta Pharmaceuticals (NASDAQ:ENTA)ENTA · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Yat Sun Or; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.